|
|
.
See Category: Diseases of the eye and adnexa
See Header: Crystalline deposits in vitreous body
ICD-10 (CM) Code and Descriptor
|
H43.20 |
Crystalline deposits in vitreous body, unspecified eye
|
H4320 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 11.28%
|
22.56%
|
18.80%
|
22.56%
|
6.02%
|
5.26%
|
1.50%
|
1.50%
|
6.77%
|
3.01%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H43.20*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
4
|
4
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
4
|
8
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
3
|
3
|
|
99212
|
OFFICE O/P EST SF 10 MIN |
3
|
3
|
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
2
|
2
|
|
99308
|
SBSQ NF CARE LOW MDM 20 |
1
|
1
|
|
67042
|
VIT FOR MACULAR HOLE |
1
|
1
|
|
J0171
|
ADRENALIN EPINEPHRINE INJECT |
1
|
10
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1
|
4
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
1
|
2
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1
|
10
|
|
J3473
|
HYALURONIDASE RECOMBINANT |
1
|
150
|
|
J7120
|
RINGERS LACTATE INFUSION |
1
|
1
|
|
J7999
|
COMPOUNDED DRUG, NOC |
1
|
1
|
|
U0002
|
COVID-19 LAB TEST NON-CDC |
1
|
1
|
|
80048
|
METABOLIC PANEL TOTAL CA |
1
|
1
|
|
85027
|
COMPLETE CBC AUTOMATED |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H43.20 related to the following DRG Codes:
124-125
|
